COMPARE · Data as of August 28, 2026
CTRE vs SBRA
Verdict: Side-by-side breakdown using the Bull Rankings model. CTRE scored 81.0, SBRA scored 71.0 — CTRE leads.
Compare another set
CTRE
CareTrust REIT, Inc.
69.4Fin
$39.03 · $9.2B
fundamentals as of
Strength gap
4.3
CTRE leads
SBRA
Sabra Health Care REIT, Inc.
65.1Fin
$20.70 · $5.3B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- Fastest growthCTRE+61.8%
- Strongest balance sheetCTRE0.72
Side by side · every name on one set of axes
Fundamentals, head-to-head
CTRE
SBRA
4.0%B+
Yield
5.8%A-
+61.8%A
Rev
+10.2%B
0.72B+
D/E
0.96B
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
The companies
CTRECareTrust REIT, Inc.
Why now
REIT - Healthcare Facilities · market cap $9.2b. 11% off the 52-week high of $43.62. Revenue growing +62% — in hypergrowth territory. 13 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $45.38 (implying +16% upside).
Moat
Net margin 62% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma.
Risk
P/S 16.1x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
SBRASabra Health Care REIT, Inc.
Why now
REIT - Healthcare Facilities · market cap $5.3b. 9% off the 52-week high of $22.77. Revenue growing +10%, comfortably above the S&P median. 14 sell-side analysts rate this a Buy with a mean 1-yr target of $22.57 (implying +9% upside).
Moat
Moat signals from the quantitative card are modest — profitability and capital efficiency are middle-of-pack. The thesis here depends on softer factors (switching costs, brand, distribution, regulatory protection) not captured by the quality-growth screen.
Risk
Dividend payout 462% of earnings on a 5.8% yield — distribution coverage is thin; one earnings stumble could force a dividend cut. ROE 2% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.